LSTM and iiCON are now seeking to procure advanced Organ-on-Chip (OoC) technologies for integration into the AIR-HC facility. The technologies sought may include, but are not limited to, models incorporating tonsillar, lung and liver tissues, with preference for multi-organ-on-chip (MOoC) platforms capable of physiologically relevant inter-organ communication. The purpose of this project is to Supply Organ on Chip technology for infectious disease research at Containment level 3 / schedule 5 pathogens biosafety laboratory. The scope of this tender includes the supply, delivery, installation and commissioning of the proposed system(s), together with any required design adaptation, packaging and shipping, user training, technical documentation, and ongoing maintenance, servicing and upgrade pathways necessary to ensure sustained cutting-edge performance within a CL3 automated environment. The procured technology will support both internal academic research programmes and commercial activities delivered through iiCON and the AIR-HC facility. Accordingly, LSTM seeks scalable, automation-compatible, and future-proof platforms suitable for integration into robotic workflows and capable of operating within the spatial and biosafety constraints of a high-containment laboratory. Solutions offering multi-organ capability within a compact footprint, and those designed to support expansion and increased throughput over time, will be particularly advantageous.